Kailera Therapeutics, Inc. (KLRA)

21.47 -1.00 (-4.45%) USD  |  NASDAQ  |  May 08, 16:00
21.57 +0.10 (+0.47%) After-Hours: 20:00
More

Kailera Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for KLRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Liminatus Pharma, Inc. Upgrade
Oruka Therapeutics, Inc. Upgrade
MapLight Therapeutics, Inc. Upgrade
Veracyte, Inc. Upgrade
Insight Molecular Diagnostics, Inc. Upgrade